Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Dynamics of Carbapenemase Genes in Enterobacter cloacae Duri

    2026-04-23

    Characterization and Transmission Dynamics of Carbapenemase-Encoding Genes in CREC

    Study Background and Research Question

    Carbapenem-resistant Enterobacteriaceae (CRE) have become a critical global health concern, with Enterobacter cloacae (CREC) ranking as the third most prevalent CRE species in China. The COVID-19 pandemic exacerbated the problem by increasing antibiotic use and complicating healthcare delivery, thereby accelerating the emergence and spread of drug-resistant pathogens. Despite the gravity of the issue, the specific transmission dynamics and molecular characteristics of carbapenemase-encoding genes (CEGs) in CREC during this period remained poorly understood. Addressing this gap, Chen et al. (2025) conducted a multicenter study across eight teaching hospitals in Guangdong Province, aiming to elucidate the prevalence, genetic context, and epidemiological patterns of CEGs in contemporary CREC isolates (paper).

    Key Innovation from the Reference Study

    The central innovation of this work lies in its integration of molecular epidemiology, plasmid profiling, and transmission analysis for CREC isolates collected during the COVID-19 pandemic. Unlike prior reports, this study differentiates the chromosomal and plasmid locations of resistance determinants, quantifies the horizontal transferability of CEGs, and correlates genetic findings with clinical and demographic risk factors. The identification of blaNDM–1 as the predominant CEG, especially when plasmid-borne, and the mapping of mobile genetic elements responsible for dissemination, represent critical advancements in understanding the real-world trajectory of multidrug-resistant bacteria during a healthcare crisis (paper).

    Methods and Experimental Design Insights

    Fifty-four non-duplicate CREC isolates were collected from December 2022 to June 2024. The variable temperature SDS plasmid elimination method, PCR for CEG detection, and broth microdilution for antimicrobial susceptibility testing were employed. Conjugation experiments assessed horizontal gene transfer potential. Mobile genetic elements were mapped by PCR, and clonal relatedness was established via ERIC-PCR and cluster analysis using NTSYS software. Clinical metadata (e.g., patient age, sex, hospital department, specimen type) were integrated for epidemiological correlation (paper).

    Protocol Parameters

    • Assay: Broth microdilution | Value: MIC90 0.12–1 μg/mL (Tigecycline) | Applicability: Antimicrobial susceptibility profiling of multidrug-resistant Enterobacteriaceae | Rationale: Allows quantification of inhibitory concentration, essential for comparing efficacy against clinical and reference strains | product_spec
    • Gene detection: PCR | Value: 85.19% CEG-positive (46/54 isolates) | Applicability: Rapid screening for major carbapenemase-encoding genes | Rationale: PCR offers sensitive detection of genetic resistance determinants | paper
    • Plasmid transfer: Conjugation assay | Value: 95.65% success (44/46 attempts) | Applicability: Evaluation of horizontal gene transfer potential among Enterobacteriaceae | Rationale: High transferability underscores the epidemiological risk of plasmid-borne resistance | paper
    • Clonal analysis: ERIC-PCR | Value: 17 genotypes identified | Applicability: Outbreak investigation and epidemiological tracing | Rationale: Discriminates between clonal spread and independent acquisition events | paper

    Core Findings and Why They Matter

    Among the 54 CREC isolates, 85.19% harbored one or more carbapenemase-encoding genes. The blaNDM–1 gene was the most prevalent, found in 33.33% of isolates on both chromosomes and plasmids, and in 46.30% exclusively on plasmids. Other CEGs, such as blaIMP and blaKPC–2, were detected at lower frequencies. Notably, CEG-positive isolates demonstrated significantly higher resistance to multiple antibiotics, including imipenem, cefepime, gentamicin, and ceftazidime/avibactam (paper). Plasmid conjugation experiments revealed that CEGs—especially blaNDM–1 and blaIMP—possess high horizontal transferability, with success rates exceeding 95%. Six types of mobile genetic elements were identified, with ISEcp1 being most common (87.04%). The presence of multiple mobile elements in a single isolate was frequent, suggesting robust mechanisms for gene dissemination. Clonal analysis divided the isolates into 17 genotypes, with two major types (E and G) dominating, pointing to both clonal expansion and horizontal gene acquisition as drivers of the local CREC epidemic (paper). Epidemiologically, higher rates of CEG-positive CREC were found in male patients (64.81%), elderly individuals (72.22%), respiratory medicine departments (20.37%), and in sputum samples (33.33%), indicating specific clinical risk profiles for targeted intervention (paper).

    Comparison with Existing Internal Articles

    Several internal resources provide complementary perspectives on the management and study of multidrug-resistant bacteria. For instance, the article "Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistant Bacteria" details the use of tigecycline—a next-generation glycylcycline antibiotic—as an experimental and clinical tool for combating resistant pathogens, including CREC (internal). That article, along with "Tigecycline: Unlocking Glycylcycline Antibiotic Power", emphasizes translational and molecular approaches to resistance, focusing on protein translation inhibition pathways and bacterial ribosome targeting—a mechanistic domain that complements the genetic and epidemiological insights from the current CREC study (internal). Notably, both the reference paper and these internal reviews underscore the challenges of resistance gene dissemination, the value of 30S ribosomal subunit inhibitors like tigecycline, and the importance of robust laboratory workflows for tackling multidrug-resistant Enterobacteriaceae. However, the reference study stands out by quantifying plasmid transfer rates and mapping genotype-phenotype correlations in a real-world pandemic context.

    Limitations and Transferability

    This study is geographically limited to Guangdong Province and relies on isolates from teaching hospitals, which may not capture the full diversity of CREC in other settings or patient populations. The cross-sectional design precludes assessment of longitudinal trends or the direct impact of specific infection control measures. Furthermore, while molecular techniques offer high-resolution insight, functional studies on gene expression and clinical outcome correlations were beyond the study’s scope (paper). The findings are nonetheless highly transferable to laboratories and infection control teams facing similar epidemiological challenges, particularly in regions with rising CREC prevalence. The methodologic rigor—combining plasmid mapping, mobile element profiling, and conjugation assays—provides a blueprint for comprehensive resistance surveillance.

    Why this cross-domain matters, maturity, and limitations

    The convergence of molecular epidemiology with experimental antimicrobial workflows (such as those using glycylcycline antibiotics) enables a more nuanced understanding of resistance transmission and therapeutic options. However, while the reference paper robustly supports genetic and epidemiological findings, the direct application to novel antibiotic testing or treatment optimization should be informed by additional translational research and clinical trials (workflow_recommendation).

    Research Support Resources

    Researchers investigating multidrug-resistant Enterobacteriaceae or planning to model gene transfer and resistance patterns in vitro can leverage specialized reagents and controls. For example, Tigecycline (SKU A5226) from APExBIO offers a well-characterized glycylcycline antibiotic standard with proven efficacy in both in vitro and in vivo infection models, including those relevant to CREC and glycopeptide-intermediate Staphylococcus aureus (source: product_spec). Its established use as a 30S ribosomal subunit inhibitor and high tissue penetration make it suitable for resistance phenotype testing and antimicrobial agent development. For detailed protocols and troubleshooting strategies, researchers are advised to consult both the product documentation and recent workflow-focused articles (internal).